NMTRQ

9 Meters Biopharma, Inc. NMTRQ

NMTRQ
9 Meters Biopharma, Inc. HMGN
Hemagen Diagnostics, Inc. FNAM
Evolutionary Genomics, Inc. RVLP
RVL Pharmaceuticals plc CFRXQ
ContraFect Corporation IMVIF
IMV Inc. THMO
ThermoGenesis Holdings, Inc. EFTR
eFFECTOR Therapeutics, Inc. ETAOF
ETAO International Co., Ltd. ONBI
ONE Bio Corp.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NMTRQ HMGN FNAM RVLP CFRXQ IMVIF THMO EFTR ETAOF ONBI
6M 9 900.00 % 0.00 % 0.00 % -96.93 % -50.00 % 0.00 % -66.67 % 0.00 % 200.00 % -93.33 %
YTD 900.00 % 0.00 % -75.00 % -97.55 % 0.00 % 0.00 % -85.71 % 19 900.00 % 2 900.00 % -93.33 %
1Y 900.00 % 0.00 % -75.00 % -98.08 % 0.00 % 0.00 % -80.00 % -81.82 % 0.00 % -93.33 %
3Y -99.99 % 0.00 % -99.97 % -99.54 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -96.00 %
5Y -100.00 % -98.59 % -99.98 % -99.60 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.39 %
10Y -100.00 % -99.64 % -99.99 % -99.65 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.80 %
From the beginning -100.00 % -100.00 % -100.00 % -99.65 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividend